Literature DB >> 32005661

Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe.

Conor J Crawford1,2, Radamés J B Cordero2, Lorenzo Guazzelli1, Maggie P Wear2, Anthony Bowen2, Stefan Oscarson3, Arturo Casadevall4.   

Abstract

Chemical biology is an emerging field that enables the study and manipulation of biological systems with probes whose reactivities provide structural insights. The opportunistic fungal pathogen Cryptococcus neoformans possesses a polysaccharide capsule that is a major virulence factor, but is challenging to study. We report here the synthesis of a hydroxylamine-armed fluorescent probe that reacts with reducing glycans and its application to study the architecture of the C. neoformans capsule under a variety of conditions. The probe signal localized intracellularly and at the cell wall-membrane interface, implying the presence of reducing-end glycans at this location where the capsule is attached to the cell body. In contrast, no fluorescence signal was detected in the capsule body. We observed vesicle-like structures containing the reducing-end probe, both intra- and extracellularly, consistent with the importance of vesicles in capsular assembly. Disrupting the capsule with DMSO, ultrasound, or mechanical shear stress resulted in capsule alterations that affected the binding of the probe, as reducing ends were exposed and cell membrane integrity was compromised. Unlike the polysaccharides in the assembled capsule, isolated exopolysaccharides contained reducing ends. The reactivity of the hydroxylamine-armed fluorescent probe suggests a model for capsule assembly whereby reducing ends localize to the cell wall surface, supporting previous findings suggesting that this is an initiation point for capsular assembly. We propose that chemical biology is a promising approach for studying the C. neoformans capsule and its associated polysaccharides to unravel their roles in fungal virulence.
© 2020 Crawford et al.

Entities:  

Keywords:  aminooxy fluorescent probes; biosynthesis; capsule; chemical biology; extracellular vesicles; fungal pathogen; fungi; glucuronoxylomannan; glycobiology; polysaccharide; reducing glycans; vesicles; virulence factor

Year:  2020        PMID: 32005661      PMCID: PMC7105310          DOI: 10.1074/jbc.RA119.012251

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence.

Authors:  Amy J Reese; Aki Yoneda; Julia A Breger; Anne Beauvais; Hong Liu; Cara L Griffith; Indrani Bose; Myoung-Ju Kim; Colleen Skau; Sarah Yang; Julianne A Sefko; Masako Osumi; Jean-Paul Latge; Eleftherios Mylonakis; Tamara L Doering
Journal:  Mol Microbiol       Date:  2007-03       Impact factor: 3.501

2.  Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level.

Authors:  Aki Yoneda; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2007-12-21

3.  Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity.

Authors:  Radames J B Cordero; Susana Frases; Allan J Guimaräes; Johanna Rivera; Arturo Casadevall
Journal:  Mol Microbiol       Date:  2011-01-05       Impact factor: 3.501

Review 4.  Chemical glycobiology.

Authors:  C R Bertozzi; L L Kiessling
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

Review 5.  Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.

Authors:  Kyung J Kwon-Chung; James A Fraser; Tamara L Doering; Zhou Wang; Guilhem Janbon; Alexander Idnurm; Yong-Sun Bahn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

6.  Serologic evidence for Cryptococcus neoformans infection in early childhood.

Authors:  D L Goldman; H Khine; J Abadi; D J Lindenberg; R Niang; A Casadevall
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

7.  Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.

Authors:  R Ikeda; H Matsuyama; A Nishikawa; T Shinoda; Y Fukazawa
Journal:  Microbiol Immunol       Date:  1991       Impact factor: 1.955

8.  Cell-wall dyes interfere with Cryptococcus neoformans melanin deposition.

Authors:  Ricardo Perez-Dulzaides; Emma Camacho; Radames J B Cordero; Arturo Casadevall
Journal:  Microbiology       Date:  2018-06-25       Impact factor: 2.777

9.  Lipophilic dye staining of Cryptococcus neoformans extracellular vesicles and capsule.

Authors:  André Moraes Nicola; Susana Frases; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2009-05-22

Review 10.  The capsule of Cryptococcus neoformans.

Authors:  Arturo Casadevall; Carolina Coelho; Radames J B Cordero; Quigly Dragotakes; Eric Jung; Raghav Vij; Maggie P Wear
Journal:  Virulence       Date:  2018-08-01       Impact factor: 5.882

View more
  2 in total

1.  A glycan FRET assay for detection and characterization of catalytic antibodies to the Cryptococcus neoformans capsule.

Authors:  Conor J Crawford; Maggie P Wear; Daniel F Q Smith; Clotilde d'Errico; Scott A McConnell; Arturo Casadevall; Stefan Oscarson
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

2.  Variation in Cell Surface Hydrophobicity among Cryptococcus neoformans Strains Influences Interactions with Amoebas.

Authors:  Raghav Vij; Carina Danchik; Conor Crawford; Quigly Dragotakes; Arturo Casadevall
Journal:  mSphere       Date:  2020-04-29       Impact factor: 4.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.